Delivery Order SPE2DB24D8002-SPE2DB24FJMPU
Award Date
7/17/24
Potential Completion Date
7/18/24
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $3,317.13, is for the delivery of the pharmaceutical product Fluticasone-Salmeterol 115-21 12GM. The contract has an ultimate completion date of February 25, 2025. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, SPE2DB24D8001, valued at $999,999,999.00, as...
This contract award, valued at $1,524.99, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of Fluticasone-Salmeterol 115-21 12GM, a pharmaceutical product. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an ultimate completion date of February 13, 2025. Dakota Drug, Inc. holds a larger, single-award Indefinite Delivery Contract (IDC) with the DLA, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $2,437.20 firm fixed-price delivery order contract is for the supply of Fluticasone-Salmeterol 115-21 12GM, a pharmaceutical product. The contract has an ultimate completion date of June 3, 2024. Dakota Drug, Inc. is an established vendor in the federal medical supply market, holding a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, identified as SPE2DB24D8003 and SPE2DB25FJTJM, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business registered in SAM.gov. The award, valued at $3,304.98, is for the delivery of fluticasone-salmeterol 115-21 12GM pharmaceutical products. This contract has an ultimate completion date of November 29, 2024, and is a firm fixed-price delivery order contract. Dakota Drug, Inc. is a key supplier for the DLA...
This federal contract award, valued at $2,698.33, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is a delivery order for Fluticasone-Salmeterol 230-21 12GM, a pharmaceutical product, with a performance period ending on March 8, 2024. Dakota Drug, Inc. is a key supplier to the DLA's Troop Support Medical division, holding a $999,999,999.00 Indefinite Delivery Contract (IDC) as part of the DLA Troop Support...
This federal contract award, valued at $3,405.30, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of fluticasone-salmeterol 115-21 12GM pharmaceutical products, which are likely used for respiratory conditions. The contract has an ultimate completion date of April 10, 2025 and is a firm fixed-price delivery order. Dakota Drug, Inc. has a significant single-award Indefinite Delivery Contract...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract, valued at $2,538.99, is for the delivery of the pharmaceutical product fluticasone-salmeterol 500-50 60s. This award is associated with Dakota Drug, Inc.'s Indefinite Delivery Contract (IDC) SPE2DB24D8001, valued at $999,999,999.00, which allows...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $3,476.84, is for the delivery of Fluticasone-Salmeterol 45-21 12GM, a pharmaceutical product. The contract does not have a set-aside designation and is set to be completed by October 29, 2024. Dakota Drug, Inc. is a key supplier to the DLA Troop Support Medical division, providing a range of pharmaceutical...
This contract award, identified as SPE2DX15D8002|SPE2DX24F2WN0, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $4,274.76 firm fixed-price delivery order is for the provision of fluticasone-salmeterol 230-21 12GM, a pharmaceutical product used for respiratory conditions. The award is not associated with a larger contract vehicle, and there is no set-aside designation. Dakota Drug, Inc. is the prime contractor, and there...
This federal contract award, SPE2DB24D8003|SPE2DB25FJTNP, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of fluticasone-salmeterol 230-21 12GM pharmaceutical products. The award has a ceiling value of $9,501.67 and is a Firm Fixed Price delivery order contract with a period of performance through December 31, 2024. This award is not associated with a set-aside program. Dakota Drug, Inc. is...